Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 4, 2021
Reporting Period: Single event date (August 4, 2021)
Business Context: The registrant is an emerging growth company incorporated in Nevada, with principal executive offices in Boca Raton, Florida. The company's common stock trades on The NASDAQ Stock Market LLC under the symbol "INMB".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The report serves solely to disclose the filing of a presentation deck as an exhibit.
Guidance, Outlook, and Risks
- Event: Item 8.01 (Other Events) discloses the filing of a slide deck (Exhibit 99.1) intended for use in a company presentation.
- Forward-Looking Statements: The company explicitly states it undertakes no duty or obligation to publicly update or revise the information contained in the presentation, though it may do so at management's discretion.
- Regulatory Note: The filing makes no admission as to the materiality of the information solely by reason of Regulation FD.
Investor Verification Checklist
- Review Exhibit 99.1 (the presentation deck) for specific details on the company's strategy or pipeline, as the 8-K text only references its existence.
- Verify the company's status as an "emerging growth company" and its election regarding extended transition periods for accounting standards.
- Check subsequent SEC filings or press releases for any updates to the information presented in the August 4, 2021 deck, as the company is not obligated to update it.